Catalyst

Slingshot members are tracking this event:

GlaxoSmithKline (GSK) Announces Release of Phase 3 Results for Shingles Vaccine ZOE-70 in New England Journal of Medicine (NEJM)

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
GSK

100%
Slingshot Insights Explained
Catalyst Date
Occurred on:
Sep 15, 2016
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Shingles, Vaccine, Zoe-70, New England Journal Of Medicine, Nejm